Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+-ATPase inhibition

Article ID	Journal	Published Year	Pages	File Type
9954840	Biomedicine & Pharmacotherapy	2018	11 Pages	PDF

Keywords

Na+K+-ATPase Synergistic effects Docetaxel Prostate cancer Docking studies

Related Topics

Health Sciences Medicine and Dentistry Oncology

Preview

$Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+-ATPase inhibition$

Authors

Izabella ThaÃs Silva, Jennifer Munkert, Elke Nolte, Naira Fernanda Zanchett Schneider, Sayonarah Carvalho Rocha, Ana Carolina Pacheco Ramos, Wolfgang Kreis, FernÃ£o Castro Braga, Rodrigo Maia de Pádua, Alex G. Taranto, Vanessa Cortes,